Anti-cholinergic effect of singulair on isolated rat's tracheal smooth muscle

Li Hsiang Cheng, Chuan Hsiang Kao, Chih Hung Wang, Yueng Hsiang Chu, Jia Yi Wang, Hsing Won Wang

研究成果: 雜誌貢獻文章同行評審

1 引文 斯高帕斯(Scopus)


Singulair (Montelukast) is a potent and selective leukotriene D4 receptor antagonist, often used in treating inflammatory conditions of the respiratory system such as allergic rhinitis and asthma. However, the eVects of singulair given intratracheally have rarely been well explored. To verify the eVect of singulair, which acts on the tracheal smooth muscle directly in vitro. We used our preparation to test the eVects of singulair on isolated rat's tracheal smooth muscle. The following assessments of singulair were performed: (1) effect on the tracheal smooth muscle resting tension, (2) eVect on contraction caused by 10-6 M methacholine as a parasympathetic mimetic, and (3) eVect of the drugs on electrically induced tracheal smooth muscle contractions. The results indicated that the addition of methacholine to the incubation medium caused the trachea to contract in a dose-dependent manner. Addition of singulair at doses of 10-5 M or above elicited a signiWcant relaxation response to 10-6 M methacholine-induced contraction Singulair could not inhibit electrical Weld stimulationinduced spike contraction. It also had a minimal eVect on the basal tension of trachea as the concentration increased. This study showed that the high concentrations of singulair also had an anti-cholinergic eVect for relieving symptoms of asthma.
頁(從 - 到)1923-1927
期刊European Archives of Oto-Rhino-Laryngology
出版狀態已發佈 - 8月 2012

ASJC Scopus subject areas

  • 耳鼻咽喉科


深入研究「Anti-cholinergic effect of singulair on isolated rat's tracheal smooth muscle」主題。共同形成了獨特的指紋。